Int-6, a highly conserved, widely expressed gene, is mutated by mouse mammary tumor virus in mammary preneoplasia

• DOI: 10.1128/jvi.69.3.1932-1938.1995
• Publication Date: 2020-01-06T21:27:23Z
• Authors: A Marchetti; F Buttitta; S Miyazaki; D Gallahan; G H Smith; R Callahan
• Keywords: Gene Expression Regulation, Viral; 0301 basic medicine; Base Sequence; Eukaryotic Initiation Factor-3; Molecular Sequence Data; Restriction Mapping; Mammary Neoplasms, Experimental; Cell Transformation, Viral; 3. Good health; Mice; Mutagenesis, Insertional; 03 medical and health sciences; Genes; Mammary Tumor Virus, Mouse; Proviruses; Proto-Oncogene Proteins; Mutation; Animals; Amino Acid Sequence; RNA, Messenger; RNA, Neoplasm; Cloning, Molecular; Precancerous Conditions

With a unique mouse mammary tumor model system in which mouse mammary tumor virus (MMTV) insertional mutations can be detected during progression from preneoplasia to frank malignancy, including metastasis, we have discovered a new common integration site (designated Int-6) for MMTV in mouse mammary tumors. MMTV was integrated into Int-6 in a mammary hyperplastic outgrowth line, its tumors and metastases, and two independent mammary tumors arising in unrelated mice. The Int-6 gene is ubiquitously expressed as a 1.4-kb RNA species in adult tissues and is detected beginning at day 8 of embryonic development. The nucleotide sequence of Int-6 is unrelated to any of the known genes in the GenBank database. MMTV integrates within introns of the gene in the opposite transcriptional orientation. In each tumor tested, this results in the expression of a truncated Int-6/long terminal repeat (LTR) chimeric RNA species which is terminated at a cryptic termination signal in the MMTV LTR. Since the nonrearranged Int-6 alleles in these tumors contain no mutations, we favor the conclusion that truncation of the Int-6 gene product either biologically activates its function or represents a dominant-negative mutation.